
AI demand got its bid back. The industry's leader got a downgrade.CoreWeave (CRWV) closed up about 25%. Its finance chief said it doesn't plan new parent-level unsecured debt through 2027 at today's yields. It plans to lean more on customer prepayments and contract-backed loans. Chipmakers led. The S&P 500 closed up 1.3% and the Nasdaq 1.6%, off their midday highs. Nvidia (NVDA) closed up 2.9%, its first gain since its board opened an inquiry into Jensen Huang. It still drew a rare downgrade. Baird cut it to neutral and its price target to $200 from $500. The bigger risk sits in Congress. Lawmakers in both parties are using the affair to push chip-export limits Nvidia has opposed. Huang's reply to three House chairs was due by the end of the day. Two of them said a subpoena is likely if he doesn't agree to a briefing. Nvidia reports Nov. 17. The Signal Investors paid for AI demand they could see. CoreWeave plans to shift more of its funding from bondholders to customers. The stock rose about 25% the day after it said so. Nvidia's risk now sits in Washington, where a quarterly report doesn't get a vote.
Traders priced out a Hegseth impeachment this year in a night. The strait kept its risk.A Polymarket contract on impeaching Defense Secretary Pete Hegseth this year fell to about 3 cents. It sat near 68 before the House voted Tuesday to send the articles to committee. That shelves the effort for this Congress. Three of the eight articles concerned the Iran war. A contract on him leaving office by year-end roughly halved. The water didn't follow the vote. Iran's army said a tanker struck a mine and caught fire in the eastern strait Wednesday. The U.S. military has said the main shipping lanes are clear of mines. Brent settled up about 1%, near $92.70. Petrobras (PBR) pumped record output and raised its 2026 spending plan by 23% to 31%. Profit still fell about 24% from the prior quarter, on a lower average Brent price and one-off charges. The shares closed down 2.5%. Energy Signal The impeachment contract went to near zero in hours. The shipping risk still trades ship by ship. Petrobras is spending more to pump more into a lower price. Record volume no longer guarantees a bigger profit.
The bond market took a holiday. The dollar did its job.Cash Treasuries were closed for Veterans Day, so Tuesday's hike repricing moved elsewhere. Japan's 10-year yield jumped about 11 basis points, and Australia's rose too. The dollar index rose about 0.7%, to its highest close of 2026. The dollar ended near 159.7 yen. Japan's last round of yen buying began in late July, with the dollar about 4 yen higher. Gold fell and dipped below $4,000 during the session. Kalshi's contract on a quarter-point December hike held in the mid-80s cents. Treasuries reopen Thursday with a 30-year bond sale, and producer prices follow Friday. Macro Signal The hike trade didn't pause for the holiday. It showed up in currencies and gold, which trade through it. Bonds reopen into a dollar at its highest close of the year and a long-bond auction.
From Our Partners Tesla and SpaceX Merging? Think Bigger…
Rumors of a SpaceX-Tesla merger are heating up, but former VC insider Luke Lango says the mainstream media is missing the bigger picture. "If these two companies converge," Lango says, "it could create $126 trillion in wealth." That's more than AI, robotics, clean energy, and driverless cars combined. And one $15 stock is at the center of it all… This ad is sent on behalf of InvestorPlace Media at 1125 N. Charles Street, Baltimore, Maryland 21201. If you're not interested in this opportunity, please click here.
Blackstone raised its bid for a company and sought a discount on fund stakes.Blackstone (BX) made a third offer for IDP Education at A$3 a share. The Australian company co-owns the IELTS test. The bid is 20% above the offer its board rejected in September, and the board will now consider it. The shares closed about 14% below the bid. Blackstone is also pitching a fund to buy real estate fund stakes at a discount, a report said. It targets holders who want cash and aims to raise at least $3 billion. In Tokyo, competition set the price. Bain Capital launched a tender for Hokuriku Electric Industry at a 72% premium. A board committee had pushed its offer higher after a rival bidder was rejected. The company cited a median Japanese take-private premium of about 47%. Capital Signal Sponsors pay up where a board or a rival can say no. They seek a discount where holders want cash. The same firm pursued both in one day. The price depends on who is waiting for the exit.
Crypto stocks rallied with AI. Bitcoin's options traders bought insurance.Bitcoin traded near $74,100, about 2% below Strategy's average cost of $75,456 a coin. Coinbase (COIN) closed up 3.1%. On the options venue Derive, traders put a 31% chance on bitcoin ending below $70,000 at Christmas. A week earlier it was 15%. After the close, MSCI published its first review under a rule against "non-operating companies". Early reports said it will remove Strategy (MSTR) at the close on Nov. 30. Strategy says funds tracking the index hold 3.1% of its shares. The stock closed up 1.1% and slipped less than 1% after hours. The Verdict Equity buyers treated crypto stocks as part of the AI rebound. Options buyers paid up to protect bitcoin. The largest corporate holder sits under water on its coins and is set to lose an index buyer at month-end.
Stocks paid for AI demand on a day the bond market was shut. CoreWeave said it would lean on customers over bondholders, and Nvidia's bounce came with a downgrade. Hegseth's impeachment was shelved for this Congress while Iran said a tanker hit a mine. The dollar and gold carried the hike trade. Blackstone raised a bid and sought a discount. Crypto stocks ran, bitcoin's options bought protection, and MSCI moved to drop Strategy. Treasuries reopen Thursday, producer prices land Friday, and Nvidia reports Nov. 17. The bond market returns to prices everyone else already set.
AI Moves Into the Biotech LabFor most of the AI boom, the money followed the hardware. Chips. Data centers. Cloud. Now the algorithms are walking into the lab. In September, a drug whose target was found by AI, and whose molecule was designed by AI, dosed its first patient in a Phase III trial. A second AI-engineered medicine is in Phase III too. We profiled the 5 companies leading the shift in a new FREE Special Report: AI Moves Into the Biotech Lab. We'll text it straight to your phone. Get the Free Report by Text → |
|